K36 Therapeutics

0 followers


K36 Therapeutics mission to translate epigenetic modulation of oncogenic pathways into first-in-class small molecule therapies.

Industries

Headquarters

Stage

Employees

Links

Org chart

Terrence Connolly
President and Chief Executive Officer

Terrence Connolly

Collapse
Chad Lewis
Senior Director of Chemistry and Manufacturing
Chong Xu
Director Board Of Directors
M. Travis Quigley
SVP. Head of Clinical Development